
About the Department
The Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From healthcare provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference?
The Position
Responsible for the leadership of Good Clinical (GCP), Distribution (GDP), and Manufacturing (GMP) Practices (GxP) support across U.S. Quality. Serves as the Quality Responsible Person for U.S. Operations in accordance with SOP194945. Oversees all aspects of advanced document management related to quality assurance, including Quality Docs, SOPs, ISO standards, contracts, promotional material, and regulatory documentation. Provides strategic vision, leadership, and direction for the U.S. Quality Unit and contributes to the strategic direction of CMR Strategic Operations and Operations and Staff Quality. Represents the U.S. in relevant global committees and meetings (e.g., R&D Quality, Global GCP Compliance Focus Group, Global Operation Quality Leadership Team Meetings, Quality Leadership Summit). Leads and implements an effective and compliant Quality Management System (QMS) across U.S. Quality, ensuring alignment with global expectations and partnerships. Serves as the key contact for all U.S. FDA GxP inspections, including GCP, PV, and Devices. Works closely with Regulatory Affairs leadership during inspections. Additionally responsible for oversight of U.S. Patient Safety outsourcing and compliance, including internal pharmacovigilance process adherence, vendor oversight, and CRO oversight. Leads the U.S. self-inspection program, ensuring a robust system of internal quality evaluation and continuous improvement.
Relationships
Reports to the Associate Vice President of US Patient Safety, Quality & GxP Compliance (PSQ&GxP). Leads the U.S. Quality organization on all aspects of GxP compliance and maintains strong cross-functional relationships across U.S. Operations and with senior global stakeholders. Ensures adherence to U.S. regulations and company SOPs while driving implementation of the QMS across U.S. Quality. Responsible for communication and conduct during FDA inspections and serves as the Novo Nordisk point of contact for global sponsor inspections by any health authority.
Essential Functions
Physical Requirements
20-30% overnight travel required.
Development of People
Supervisory. Ensures all reporting personnel have annual Individual Development Plans (IDPs) with goals aligned to business priorities. Ensures IDPs include learning and career aspiration plans to enable professional growth and succession readiness. Ensures the communication and application of all Novo Nordisk policies, procedures, and the Novo Nordisk Way.
Qualifications
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html